- Home
- GOOD vs ARCT Comparison
GOOD vs ARCT Comparison
Compare GOOD & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOOD
- ARCT
- Stock Information
- Founded
- GOOD 2003
- ARCT 2013
- Country
- GOOD United States
- ARCT United States
- Employees
- GOOD N/A
- ARCT N/A
- Industry
- GOOD Real Estate Investment Trusts
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- GOOD Real Estate
- ARCT Health Care
- Exchange
- GOOD Nasdaq
- ARCT Nasdaq
- Market Cap
- GOOD 578.7M
- ARCT 526.5M
- IPO Year
- GOOD N/A
- ARCT N/A
- Fundamental
- Price
- GOOD $11.51
- ARCT $11.48
- Analyst Decision
- GOOD
- ARCT Strong Buy
- Analyst Count
- GOOD 0
- ARCT 10
- Target Price
- GOOD N/A
- ARCT $48.63
- AVG Volume (30 Days)
- GOOD 525.1K
- ARCT 1.7M
- Earning Date
- GOOD 11-03-2025
- ARCT 11-06-2025
- Dividend Yield
- GOOD 10.44%
- ARCT N/A
- EPS Growth
- GOOD N/A
- ARCT N/A
- EPS
- GOOD 0.36
- ARCT N/A
- Revenue
- GOOD $153,643,000.00
- ARCT $122,122,000.00
- Revenue This Year
- GOOD $7.51
- ARCT N/A
- Revenue Next Year
- GOOD $4.39
- ARCT $34.32
- P/E Ratio
- GOOD $32.26
- ARCT N/A
- Revenue Growth
- GOOD 5.85
- ARCT N/A
- 52 Week Low
- GOOD $11.26
- ARCT $8.04
- 52 Week High
- GOOD $17.88
- ARCT $24.17
- Technical
- Relative Strength Index (RSI)
- GOOD 30.66
- ARCT 31.95
- Support Level
- GOOD $11.41
- ARCT $20.40
- Resistance Level
- GOOD $11.71
- ARCT $24.14
- Average True Range (ATR)
- GOOD 0.24
- ARCT 2.03
- MACD
- GOOD 0.03
- ARCT -0.63
- Stochastic Oscillator
- GOOD 23.33
- ARCT 15.32
About GOOD Gladstone Commercial Corporation Real Estate Investment Trust
Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.